In addition, Trono et al. found the hMENA11a isoform sustains cell proliferation and survival in HER2-overexpressing breast cancer cells primarily through activating the HER3/AKT axis, and contributes to HER3-mediated resistance mechanisms to PI3K inhibitors [21]. This evidence concerns the gene AKT1 and breast cancer.